发明名称 Aglycosylated Fc-containing polypeptides with cysteine substitutions
摘要 Provided herein are IL-2 muteins and IL-2 mutein Fc-fusion molecules that preferentially expand and activate T regulatory cells and are amenable to large scale production. Also provided herein are variant human IgG1 Fc molecules lacking or with highly reduced effector function and high stability despite lacking glycosylation at N297. Also, provided herein are linker peptides that are glycosylated when expressed in mammalian cells.
申请公布号 US9546203(B2) 申请公布日期 2017.01.17
申请号 US201414209914 申请日期 2014.03.13
申请人 Amgen Inc. 发明人 Kannan Gunasekaran
分类号 C07K16/00;C07K14/55;A61K38/00 主分类号 C07K16/00
代理机构 代理人 Kong Lawrence B.
主权项 1. A polypeptide comprising an Fc region of a human IgGl antibody wherein said Fc region comprises a N297G mutation, using EU numbering scheme, one or more substitutions of the amino acid sequence set forth in SEQ ID NO: 3 at position V259, A287, R292, V302, L306, V323, or I332, using EU numbering scheme, with a cysteine amino acid residue, and said Fc region of a human IgGl comprises at least 95% identity to the amino acid sequence set forth in SEQ ID NO:3.
地址 Thousand Oaks CA US